Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shape-Dependent Self-Assembled Targeting Peptide Electrosensitizer for Enhanced Radiofrequency Ablation of Lipid-Rich Atherosclerotic Plaques.

Journal of biomedical materials research. Part B, Applied biomaterials·2026
Same author

Living Inorganic Nanomaterials: Design, Preparation, and Biomedical Applications.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

In-situ cascade assembled peptide-drug conjugate for the treatment of bladder cancer by enhancing membrane-entry and lysosome destabilization.

Biomaterials·2026
Same author

Integrated theranostic nanoplatform empowers precision cancer care via radionuclide-labeled NIR-II aggregation-induced emission luminogens.

Nature communications·2026
Same author

An Ex Vivo Patient-Derived Tumor-Bearing Human Kidney Model Recapitulates Drug Toxicity and Metabolic Distribution.

Research (Washington, D.C.)·2026
Same author

In situ self-assembled glycopeptide regulates tumor microenvironment for tumor immunotherapy.

Journal of controlled release : official journal of the Controlled Release Society·2026

Related Experiment Video

Updated: Jun 15, 2025

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

8.1K

Stimuli-Responsive Nanomaterials for Tumor Immunotherapy.

Xiang-Peng Li1,2, Da-Yong Hou1, Jiong-Cheng Wu1

  • 1NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Heilongjiang Key Laboratory of Scientific Research in Urology, Department of Urology, Harbin Medical University Cancer Hospital, Harbin, 150001, P. R. China.

ACS Biomaterials Science & Engineering
|August 22, 2024
PubMed
Summary

Stimuli-responsive nanomaterials offer a novel approach to cancer immunotherapy by precisely targeting tumors. This strategy aims to improve treatment efficacy and reduce side effects for better patient outcomes.

Keywords:
immunotherapynanomaterialsself-assemblystimuli-responsive

More Related Videos

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.1K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.5K

Related Experiment Videos

Last Updated: Jun 15, 2025

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

8.1K
Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.1K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.5K

Area of Science:

  • Oncology
  • Nanotechnology
  • Immunotherapy

Background:

  • Cancer presents a significant global health challenge, necessitating advanced therapeutic strategies beyond conventional treatments.
  • Current tumor immunotherapy shows promise but faces limitations such as low response rates and immune-related adverse effects.
  • The development of targeted therapies that selectively eliminate cancer cells while sparing healthy tissue is crucial.

Purpose of the Study:

  • To review recent advancements in stimuli-responsive nanomaterials for tumor immunotherapy.
  • To analyze the clinical applications, advantages, and limitations of these nanomaterials.
  • To highlight the potential of stimuli-responsive nanomaterials in enhancing anti-cancer immune responses and improving patient outcomes.

Main Methods:

  • Review of endogenous and exogenous stimuli-responsive nanomaterials utilized in cancer immunotherapy research.
  • Analysis of nanomaterial targeting strategies based on tumor microenvironment signals (e.g., pH, temperature).
  • Evaluation of therapeutic agent delivery mechanisms and their impact on healthy tissues.

Main Results:

  • Stimuli-responsive nanomaterials demonstrate unique properties for precise drug delivery within the tumor microenvironment.
  • These materials can be triggered by specific signals, allowing for controlled release of therapeutic agents.
  • Combining immunotherapy with these nanomaterials shows potential for optimizing tumor-killing effects.

Conclusions:

  • Stimuli-responsive nanomaterials represent a promising frontier in cancer immunotherapy, offering enhanced targeting and reduced toxicity.
  • Further research and clinical translation are needed to fully realize their potential in improving cancer treatment efficacy.
  • These advanced materials hold significant promise for overcoming current limitations in cancer immunotherapy and improving patient survival rates.